Acurx Pharmaceuticals
ACXP
ACXP
25 hedge funds and large institutions have $2.71M invested in Acurx Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 4 closing their positions.
Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
9
Reduced
3
Closed
4
Calls
$78K
Puts
$56K
Net Calls
+$22K
Net Calls Change
+$9K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$104K |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$293K |
| 3 |
3
LPL Financial
San Diego,
California
|
$121K |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$61.4K |
| 5 |
5
BlackRock
New York
|
$61.9K |
